A federal court has ordered the U.S. Drug Enforcement Administration (DEA) to file a written response to a lawsuit filed by a research company seeking for an explanation about the status of the applications submitted to the DEA by entities that expressed interest in growing research-grade marijuana.
In 2016, the DEA called for applications from interested parties that wished to be licensed to grow marijuana for research purposes in order to supplement what was available from the only licensed facility at Mississippi University.
To date, the DEA doesn’t appear to have taken any action regarding the processing of those applications which were submitted years ago.
Researchers from the Scottsdale Research Institute (SRI) therefore went to court to compel the DEA to explain why additional manufacturers of research-grade cannabis haven’t been licensed since 2016 and yet the products currently available from Mississippi University are woefully inadequate in terms of quality and quantity.
In fact, research done on the products from Mississippi found that qualitatively, the marijuana availed to researchers by the licensed grower was closer to industrial hemp that being similar to the marijuana available at licensed dispensaries in states where cannabis is legal.
SRI, one of the entities which submitted an application to grow marijuana for research purposes, now wants the courts of law to resolve the matter of the DEA dragging its feet on making a decision on the applications submitted.
The D.C. Circuit of the U.S. Court of Appeals seems to agree with the research group and has written an order to the DEA asking the agency to submit a response, in less than 7,800 words, to the petition filed by SRI. The court has given the federal agency 30 days within which to submit their response.
In a press statement, SRI contends that the actions or inactions of the DEA are counter to the spirit of the Controlled Substances Act, and harms the interests of SRI as well as the veterans who would benefit from the research that SRI wants to conduct on the therapeutic effects of marijuana on people suffering from PTSD.
SRI further argues that everyone, including the federal government, agrees that independent marijuana research is needed, so there is no reason why the DEA continues to stonewall companies which are interested in conducting this needed research.
Attorney General William Barr took office in February with the promise that he would look into the status of the applications before the DEA from entities that wished to grow and manufacture marijuana products for research purposes. However, he too has done nothing on the matter, just like his predecessor Jeff Sessions.
Industry analysts believe that the entire marijuana industry, including players like The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) and The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), will be following this lawsuit closely since the outcome could make it easier for reliable research to be done on the medicinal effects of cannabis, or any other area of interest on this plant.
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Do you have a questions or are you interested in working with CNW420? Ask our Editor